Sponsored Research According to Therapeutic Area in 2022
Top therapeutic areas (excluding bioequivalence studies) of sponsored research conducted in 2022 are in Oncology & Hemato-Onco, Infectious Disease and Cardiology
Classification of Interventional Studies in Malaysia, 2022
Phase III form the largest type of sponsored interventional research, followed by Phase II studies.
Top trial sites based on new sponsored research in 2022
Top sites based on new interventional sponsored research in 2022
Top Sponsors that contributed to new sponsored research in 2022
Novartis, Johnson & Johnson and AstraZeneca were the top 3 sponsors in 2022.
Top CROs that contributed to new sponsored research in 2022
IQVIA, PAREXEL and Novotech were the top 3 contract research organisations in 2022.
